Adam M. Slater

Adam M. Slater is highly regarded as one of New Jersey’s most respected trial lawyers and a senior member of Mazie Slater Katz & Freeman, LLC. Mr. Slater specializes in complex civil litigation cases, including mass torts against pharmaceutical companies and medical device manufacturers, personal injury, medical malpractice, product liability, construction accidents, wrongful death, class actions, and commercial litigation. He has established a national and international reputation as a hard-nosed, aggressive, and creative courtroom lawyer who welcomes challenges and opportunities to fight for the rights of his clients.

Adam Slater has secured numerous multi-million dollar jury verdicts at trial and multi-million dollar settlements for his clients, with his verdicts and settlements totaling in the hundreds of millions of dollars.  Many of Adam Slater’s recoveries, including his most significant recoveries, are confidential and the details cannot be disclosed. Examples of Adam Slater’s verdicts and settlements, which also demonstrate the wide scope of his experience, include the following:

*Results will vary depending on your particular facts and legal circumstances.

In addition to his track record as a trial lawyer in the courtroom, Mr. Slater has extensive experience as an appellate lawyer, having argued many appeals, including in the New Jersey Supreme Court, New Jersey Appellate Division, and in the Third Circuit Court of Appeals.

Adam Slater has taken a leadership role in large, complex national litigations. He was appointed as plaintiffs’ lead counsel in the New Jersey state court consolidated litigation involving thousands of pelvic mesh cases filed against Johnson & Johnson and its subsidiary Ethicon, Inc., and C.R. Bard, Inc. In February, 2013 Mr. Slater was lead trial counsel in the first pelvic mesh trial against Johnson & Johnson and Ethicon in the United States, resulting in a compensatory and punitive damages verdict of $11.1 Million. He obtained additional pelvic mesh verdicts of $12.5 Million, $15 Million, and $68 Million, with those cases settled during or after the appeals filed by the defendants. Learn more about Pelvic Mesh Litigation and our firm’s successes in this area.

Adam Slater has also established an international presence through his legal work in pelvic mesh. On February 24, 2015 Mr. Slater testified before the Scottish Parliament on behalf of severely injured women in support of a petition to ban pelvic mesh devices in Scotland.  He informed the Parliament of the horrible complications caused by the devices, deceptive marketing, manipulation of medical societies and medical journals, and the destruction by Johnson & Johnson of tens of thousands of relevant documents, among other topics during his testimony.  This testimony helped to persuade the Scottish government to ban pelvic mesh implants. Transcript

Adam Slater’s leadership roles also include his appointment as co-lead counsel for the plaintiffs in the ongoing federal class action and mass tort cases titled: Valsartan, Irbesartan, and Losartan Federal Multi-District Litigation (“MDL”). This litigation is assigned to the District of New Jersey and involve economic loss class actions, medical monitoring class actions, and claims on behalf of individuals who were diagnosed with cancer related to the use of blood pressure pills contaminated with NDMA and NDEA, substances that are genotoxic, probable human carcinogens, and are used to give cancer to laboratory animals.

Adam Slater has been appointed co-lead counsel for the New Jersey mass tort litigation against Novo Nordisk, the manufacturer of Ozempic and Wegovy.  The litigation is based on Novo’s failure to warn of the risk of NAION, non-arteritic ischemic optic nerve damage leading to loss of visual fields and in some cases blindness.

Adam Slater has been appointed co-lead counsel for the New Jersey mass tort litigation against C.R. Bard, the manufacturer of Bard implanable power ports, used for delivery of chemotherapy and other medications, for fractures, infections, embolisms, and other complications caused by defects in the medical devices.

Adam Slater has also been appointed as lead counsel for the plaintiffs in the New Jersey State Court Multi-County Litigation (“MCL”) and as a plaintiffs’ Executive Committee member for the Federal MDL, with regard to Allergan BIOCELL textured breast implants that cause BIA-ALCL, a form of lymphoma.

He was also appointed as plaintiffs’ co-lead counsel for the Benicar (Olmesartan) federal MDL in the District of New Jersey, related to the manufacturer’s failure to warn of severe intestinal side effects very similar to celiac disease that settled for $358 Million. 

Mr. Slater was also co-class counsel in a class action against Volkswagen and Audi that settled for benefits worth $84 Million. 

*Results may vary depending on your particular facts and legal circumstances.

Adam Slater is consulted and interviewed by the media regarding complex litigation issues. He has been interviewed by both the national and international media, including Bloomberg News, The Wall Street Journal, the BBC, PBS, the Netherlands RADAR TV, and other outlets.

Adam Slater has been featured in documentary films and podcasts, including:

Adam M. Slater is a Certified Civil Trial Attorney designated by the New Jersey Supreme Court, a distinction earned by less than 2% of attorneys in New Jersey. His achievements have earned him recognition in Super Lawyers, Best Lawyers in America, and the Law Dragon 500 list of leading consumer lawyers in the United States. 

Mr. Slater frequently shares his trial expertise through lectures for legal organizations including the New Jersey Institute for Continuing Legal Education, the American Association for Justice, the New Jersey Association for Justice, Harris Martin, and Mass Torts Made Perfect. 

He has been honored with the Essex County Bar Association with the Civil Trial Attorney Achievement Award, and the New Jersey Law Journal Personal Injury Hall of Fame, for his work in the field of medical malpractice.

He earned his B.A. from Tulane University in 1989 and his J.D. from Boston University in 1993, where he was a Paul J. Liacos Scholar and an Edward F. Hennessey Scholar. 

Mr. Slater is admitted to practice in New Jersey, the District of New Jersey, the Third Circuit Court of Appeals, and New York, and has tried cases in numerous courts across the United States. He maintains active membership in the New Jersey State Bar Association, Essex County Bar Association, American Association for Justice, and New Jersey Association for Justice.

Watch Adam Slater’s Opening Statement in the medical malpractice/wrongful death trial in Estate of David Tobe v. Trinity Hospital, et al., in the New Jersey State Court in October, 2014.

Watch Adam Slater’s Cross-Examination of urogynecologist Dr. Miles Murphy, an expert witness for Johnson & Johnson/Ethicon during the first pelvic mesh case to go to trial in the United States against Johnson & Johnson/Ethicon.

Watch Adam Slater’s Cross-Examination of urogynecologist Dr. Piet Hinoul, a worldwide medical director at Johnson & Johnson/Ethicon during the first pelvic mesh case to go to trial in the United States against Johnson & Johnson/Ethicon.

Watch Adam Slater’s Closing Argument during the first pelvic mesh case to go to trial in the United States against Johnson & Johnson/Ethicon.